| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteogenesis Imperfecta | 16 | 2024 | 150 | 5.370 |
Why?
|
| Bone and Bones | 10 | 2020 | 266 | 2.380 |
Why?
|
| Osteoblasts | 6 | 2024 | 149 | 2.260 |
Why?
|
| Osteogenesis | 9 | 2024 | 154 | 2.190 |
Why?
|
| Genetic Therapy | 6 | 2018 | 687 | 1.460 |
Why?
|
| Proteoglycans | 3 | 2018 | 88 | 1.440 |
Why?
|
| SOX9 Transcription Factor | 2 | 2024 | 80 | 1.380 |
Why?
|
| Mutation | 27 | 2024 | 5845 | 1.380 |
Why?
|
| Tacrolimus Binding Proteins | 3 | 2021 | 66 | 1.370 |
Why?
|
| Urea Cycle Disorders, Inborn | 6 | 2019 | 77 | 1.290 |
Why?
|
| Chondrogenesis | 5 | 2022 | 26 | 1.280 |
Why?
|
| Wnt1 Protein | 4 | 2018 | 71 | 1.250 |
Why?
|
| Osteochondrodysplasias | 4 | 2017 | 66 | 1.190 |
Why?
|
| MAP Kinase Signaling System | 3 | 2024 | 313 | 1.170 |
Why?
|
| Osteoarthritis | 4 | 2018 | 86 | 1.160 |
Why?
|
| Motor Activity | 2 | 2021 | 522 | 1.160 |
Why?
|
| Cartilage, Articular | 3 | 2018 | 57 | 1.150 |
Why?
|
| Osteocytes | 2 | 2017 | 15 | 1.110 |
Why?
|
| Bone Density | 6 | 2017 | 318 | 1.090 |
Why?
|
| Awards and Prizes | 2 | 2018 | 65 | 1.050 |
Why?
|
| Exome | 15 | 2020 | 1033 | 1.020 |
Why?
|
| Intellectual Disability | 10 | 2024 | 1056 | 0.980 |
Why?
|
| Fractures, Bone | 3 | 2017 | 185 | 0.970 |
Why?
|
| Cell Differentiation | 5 | 2024 | 1896 | 0.970 |
Why?
|
| Rare Diseases | 3 | 2018 | 191 | 0.960 |
Why?
|
| MicroRNAs | 3 | 2018 | 838 | 0.940 |
Why?
|
| Membrane Proteins | 6 | 2024 | 1529 | 0.900 |
Why?
|
| Chondrocytes | 4 | 2021 | 50 | 0.880 |
Why?
|
| Ehlers-Danlos Syndrome | 2 | 2022 | 46 | 0.880 |
Why?
|
| Collagen | 5 | 2022 | 318 | 0.850 |
Why?
|
| Mice | 34 | 2024 | 17644 | 0.840 |
Why?
|
| Receptor, Notch1 | 2 | 2014 | 64 | 0.830 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2021 | 156 | 0.820 |
Why?
|
| Animals | 43 | 2024 | 34234 | 0.820 |
Why?
|
| Platelet-Rich Plasma | 2 | 2021 | 15 | 0.810 |
Why?
|
| Collagen Type II | 4 | 2017 | 24 | 0.790 |
Why?
|
| Cartilage | 4 | 2018 | 49 | 0.780 |
Why?
|
| Phenotype | 17 | 2022 | 4258 | 0.770 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2018 | 54 | 0.740 |
Why?
|
| Bone Diseases | 2 | 2020 | 43 | 0.740 |
Why?
|
| Joints | 1 | 2021 | 23 | 0.740 |
Why?
|
| Achilles Tendon | 1 | 2021 | 10 | 0.740 |
Why?
|
| Patellar Ligament | 1 | 2021 | 12 | 0.730 |
Why?
|
| Transforming Growth Factor beta | 3 | 2022 | 459 | 0.700 |
Why?
|
| Adenoviridae | 4 | 2018 | 606 | 0.700 |
Why?
|
| Osteoporosis | 3 | 2017 | 117 | 0.700 |
Why?
|
| Collagen Type I | 7 | 2022 | 112 | 0.700 |
Why?
|
| Hydroxylation | 4 | 2021 | 45 | 0.690 |
Why?
|
| Mice, Transgenic | 9 | 2024 | 2396 | 0.690 |
Why?
|
| Disease Models, Animal | 13 | 2022 | 4396 | 0.660 |
Why?
|
| Signal Transduction | 8 | 2023 | 4534 | 0.640 |
Why?
|
| Hyperammonemia | 3 | 2015 | 62 | 0.630 |
Why?
|
| Leukocytes | 2 | 2021 | 210 | 0.610 |
Why?
|
| Hyperalgesia | 1 | 2018 | 25 | 0.610 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2019 | 282 | 0.610 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2018 | 47 | 0.590 |
Why?
|
| Cartilage Diseases | 1 | 2018 | 13 | 0.590 |
Why?
|
| Blepharophimosis | 3 | 2020 | 26 | 0.590 |
Why?
|
| Argininosuccinate Lyase | 1 | 2018 | 57 | 0.590 |
Why?
|
| Gene Deletion | 2 | 2021 | 789 | 0.580 |
Why?
|
| Osteoclasts | 3 | 2020 | 55 | 0.570 |
Why?
|
| Bone Remodeling | 1 | 2018 | 55 | 0.570 |
Why?
|
| Arthritis, Experimental | 2 | 2018 | 15 | 0.570 |
Why?
|
| Transduction, Genetic | 1 | 2018 | 288 | 0.570 |
Why?
|
| Aspirin | 1 | 2019 | 221 | 0.560 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2018 | 443 | 0.550 |
Why?
|
| Carrier Proteins | 5 | 2023 | 1024 | 0.540 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2014 | 77 | 0.540 |
Why?
|
| Homeostasis | 3 | 2020 | 700 | 0.530 |
Why?
|
| Ammonia | 2 | 2015 | 75 | 0.520 |
Why?
|
| Ubiquitination | 1 | 2017 | 168 | 0.520 |
Why?
|
| Genetics, Medical | 1 | 2017 | 118 | 0.510 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 191 | 0.510 |
Why?
|
| Serpins | 1 | 2015 | 27 | 0.500 |
Why?
|
| Humans | 69 | 2024 | 124700 | 0.500 |
Why?
|
| Male | 45 | 2024 | 61314 | 0.500 |
Why?
|
| Hyperargininemia | 1 | 2015 | 13 | 0.500 |
Why?
|
| Regeneration | 1 | 2018 | 214 | 0.500 |
Why?
|
| Histone Acetyltransferases | 3 | 2020 | 314 | 0.500 |
Why?
|
| Nerve Growth Factors | 1 | 2015 | 71 | 0.490 |
Why?
|
| Leadership | 1 | 2018 | 228 | 0.490 |
Why?
|
| Arginase | 1 | 2015 | 32 | 0.490 |
Why?
|
| Critical Illness | 1 | 2020 | 599 | 0.490 |
Why?
|
| Osteoarthritis, Knee | 2 | 2021 | 244 | 0.480 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 366 | 0.470 |
Why?
|
| Endothelial Cells | 1 | 2018 | 526 | 0.470 |
Why?
|
| Osteosarcoma | 2 | 2014 | 253 | 0.460 |
Why?
|
| Eye Proteins | 1 | 2015 | 218 | 0.450 |
Why?
|
| Glutamine | 1 | 2015 | 215 | 0.450 |
Why?
|
| Mice, Knockout | 11 | 2021 | 3742 | 0.450 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2014 | 16 | 0.450 |
Why?
|
| Genotyping Techniques | 1 | 2014 | 103 | 0.450 |
Why?
|
| Child, Preschool | 24 | 2021 | 13882 | 0.440 |
Why?
|
| Abnormalities, Multiple | 5 | 2018 | 958 | 0.440 |
Why?
|
| Craniofacial Abnormalities | 2 | 2013 | 240 | 0.440 |
Why?
|
| Female | 43 | 2024 | 66570 | 0.430 |
Why?
|
| Codon, Initiator | 1 | 2013 | 8 | 0.430 |
Why?
|
| Pedigree | 9 | 2022 | 1604 | 0.420 |
Why?
|
| Urogenital Abnormalities | 2 | 2012 | 154 | 0.420 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2013 | 21 | 0.420 |
Why?
|
| 5' Untranslated Regions | 1 | 2013 | 58 | 0.420 |
Why?
|
| Arginine | 1 | 2015 | 333 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 4407 | 0.410 |
Why?
|
| Psychomotor Disorders | 1 | 2012 | 28 | 0.400 |
Why?
|
| Blepharoptosis | 2 | 2012 | 67 | 0.400 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2012 | 11 | 0.400 |
Why?
|
| Receptor, Notch2 | 1 | 2012 | 9 | 0.390 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 2523 | 0.390 |
Why?
|
| Genotype | 5 | 2019 | 2558 | 0.390 |
Why?
|
| Noonan Syndrome | 1 | 2012 | 30 | 0.380 |
Why?
|
| Point Mutation | 1 | 2013 | 347 | 0.380 |
Why?
|
| Knee Joint | 1 | 2013 | 158 | 0.380 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 410 | 0.370 |
Why?
|
| Child | 25 | 2022 | 24170 | 0.370 |
Why?
|
| Bone Neoplasms | 2 | 2020 | 419 | 0.360 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 207 | 0.360 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2016 | 882 | 0.360 |
Why?
|
| Tendons | 3 | 2021 | 41 | 0.350 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 325 | 0.350 |
Why?
|
| Phenylbutyrates | 3 | 2015 | 58 | 0.350 |
Why?
|
| Marfan Syndrome | 1 | 2012 | 141 | 0.350 |
Why?
|
| Molecular Chaperones | 4 | 2022 | 167 | 0.350 |
Why?
|
| Developmental Disabilities | 4 | 2020 | 711 | 0.340 |
Why?
|
| Hypertension | 1 | 2018 | 1329 | 0.330 |
Why?
|
| Proteins | 2 | 2014 | 1035 | 0.320 |
Why?
|
| Radiography | 5 | 2016 | 814 | 0.320 |
Why?
|
| Stem Cells | 3 | 2024 | 706 | 0.320 |
Why?
|
| Genetic Association Studies | 4 | 2017 | 778 | 0.300 |
Why?
|
| Haploinsufficiency | 3 | 2022 | 258 | 0.300 |
Why?
|
| Liver | 1 | 2015 | 1742 | 0.300 |
Why?
|
| Lysine | 2 | 2021 | 195 | 0.300 |
Why?
|
| Animals, Newborn | 4 | 2021 | 1017 | 0.300 |
Why?
|
| X-Ray Microtomography | 4 | 2018 | 85 | 0.300 |
Why?
|
| Mice, 129 Strain | 2 | 2021 | 98 | 0.300 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2023 | 429 | 0.290 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2021 | 3154 | 0.280 |
Why?
|
| Genetic Testing | 3 | 2020 | 1002 | 0.280 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2017 | 166 | 0.270 |
Why?
|
| Heterozygote | 6 | 2021 | 671 | 0.260 |
Why?
|
| Microcephaly | 2 | 2022 | 330 | 0.260 |
Why?
|
| Gene Transfer Techniques | 3 | 2018 | 357 | 0.260 |
Why?
|
| History, 21st Century | 2 | 2018 | 265 | 0.260 |
Why?
|
| Base Sequence | 4 | 2015 | 3101 | 0.260 |
Why?
|
| Procollagen-Proline Dioxygenase | 2 | 2017 | 36 | 0.250 |
Why?
|
| History, 20th Century | 2 | 2018 | 380 | 0.250 |
Why?
|
| Amino Acids | 2 | 2018 | 666 | 0.250 |
Why?
|
| Adolescent | 15 | 2021 | 19216 | 0.240 |
Why?
|
| Liver Transplantation | 2 | 2014 | 1031 | 0.240 |
Why?
|
| Glycerol | 2 | 2015 | 97 | 0.240 |
Why?
|
| Infant | 13 | 2021 | 12381 | 0.240 |
Why?
|
| Sequence Analysis, DNA | 6 | 2018 | 1757 | 0.240 |
Why?
|
| Seizures | 3 | 2021 | 870 | 0.230 |
Why?
|
| Nutritional Status | 1 | 2006 | 314 | 0.230 |
Why?
|
| Limb Deformities, Congenital | 2 | 2016 | 106 | 0.220 |
Why?
|
| Cohort Studies | 4 | 2020 | 4799 | 0.220 |
Why?
|
| HEK293 Cells | 2 | 2017 | 737 | 0.220 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 3891 | 0.220 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2024 | 145 | 0.220 |
Why?
|
| Homozygote | 2 | 2017 | 547 | 0.210 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 552 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 765 | 0.210 |
Why?
|
| Ligaments | 2 | 2021 | 19 | 0.210 |
Why?
|
| Cells, Cultured | 3 | 2018 | 3055 | 0.210 |
Why?
|
| Bone Diseases, Developmental | 4 | 2017 | 58 | 0.200 |
Why?
|
| Mutation, Missense | 3 | 2018 | 874 | 0.200 |
Why?
|
| Heart Defects, Congenital | 3 | 2018 | 1816 | 0.200 |
Why?
|
| Genetic Variation | 2 | 2020 | 1498 | 0.200 |
Why?
|
| Extracellular Matrix | 2 | 2021 | 238 | 0.200 |
Why?
|
| Cataract | 2 | 2015 | 224 | 0.200 |
Why?
|
| Collagen Type V | 1 | 2022 | 4 | 0.200 |
Why?
|
| Genes, Recessive | 2 | 2021 | 185 | 0.200 |
Why?
|
| Adult | 15 | 2024 | 29555 | 0.200 |
Why?
|
| Gene Expression | 3 | 2017 | 1561 | 0.200 |
Why?
|
| Young Adult | 9 | 2021 | 9022 | 0.200 |
Why?
|
| Cell Line | 3 | 2017 | 2757 | 0.190 |
Why?
|
| Sequence Deletion | 2 | 2015 | 524 | 0.190 |
Why?
|
| Fibrillar Collagens | 1 | 2021 | 15 | 0.190 |
Why?
|
| Malformations of Cortical Development | 2 | 2018 | 52 | 0.180 |
Why?
|
| Hand Strength | 1 | 2021 | 40 | 0.180 |
Why?
|
| Physical Endurance | 1 | 2021 | 44 | 0.180 |
Why?
|
| Ossification, Heterotopic | 1 | 2021 | 41 | 0.180 |
Why?
|
| Phosphorylation | 3 | 2021 | 1631 | 0.180 |
Why?
|
| Genetic Vectors | 2 | 2018 | 941 | 0.180 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2021 | 97 | 0.180 |
Why?
|
| NF-kappa B | 2 | 2021 | 460 | 0.180 |
Why?
|
| Fasting | 2 | 2015 | 294 | 0.170 |
Why?
|
| Spectrin | 1 | 2021 | 63 | 0.170 |
Why?
|
| Micrognathism | 3 | 2018 | 65 | 0.170 |
Why?
|
| Hedgehog Proteins | 1 | 2021 | 188 | 0.170 |
Why?
|
| Hand Deformities, Congenital | 3 | 2018 | 88 | 0.170 |
Why?
|
| Diphosphonates | 1 | 2020 | 38 | 0.170 |
Why?
|
| Gait | 1 | 2021 | 146 | 0.170 |
Why?
|
| Receptors, Notch | 2 | 2020 | 201 | 0.170 |
Why?
|
| Cross-Linking Reagents | 2 | 2017 | 55 | 0.170 |
Why?
|
| eIF-2 Kinase | 1 | 2020 | 35 | 0.170 |
Why?
|
| Nitrogen | 1 | 2020 | 146 | 0.170 |
Why?
|
| Growth Disorders | 3 | 2016 | 209 | 0.170 |
Why?
|
| Apc1 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 2019 | 3 | 0.160 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2019 | 20 | 0.160 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 59 | 0.160 |
Why?
|
| Fibrosis | 1 | 2021 | 435 | 0.160 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2019 | 27 | 0.160 |
Why?
|
| Amino Acid Sequence | 4 | 2017 | 2717 | 0.160 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2019 | 44 | 0.160 |
Why?
|
| Rothmund-Thomson Syndrome | 1 | 2019 | 47 | 0.160 |
Why?
|
| Actins | 1 | 2021 | 345 | 0.160 |
Why?
|
| Stifle | 1 | 2018 | 1 | 0.150 |
Why?
|
| Thrombin | 1 | 2019 | 60 | 0.150 |
Why?
|
| Pigmentation Disorders | 1 | 2018 | 23 | 0.150 |
Why?
|
| Osteophyte | 1 | 2018 | 7 | 0.150 |
Why?
|
| Platelet Activation | 1 | 2019 | 71 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 370 | 0.150 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2018 | 13 | 0.150 |
Why?
|
| Megalencephaly | 1 | 2018 | 57 | 0.150 |
Why?
|
| Adipocytes | 1 | 2019 | 141 | 0.150 |
Why?
|
| Synovitis | 1 | 2018 | 25 | 0.150 |
Why?
|
| Hearing Loss | 1 | 2019 | 135 | 0.150 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 129 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2017 | 358 | 0.150 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 130 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2024 | 502 | 0.150 |
Why?
|
| Biomarkers | 2 | 2019 | 3083 | 0.150 |
Why?
|
| Drosophila Proteins | 1 | 2024 | 712 | 0.150 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2017 | 12 | 0.150 |
Why?
|
| Delphi Technique | 1 | 2019 | 207 | 0.150 |
Why?
|
| Peptides | 1 | 2021 | 810 | 0.140 |
Why?
|
| Autistic Disorder | 1 | 2021 | 350 | 0.140 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 117 | 0.140 |
Why?
|
| Fibronectins | 1 | 2017 | 110 | 0.140 |
Why?
|
| Diagnosis, Differential | 3 | 2018 | 1872 | 0.140 |
Why?
|
| Calcification, Physiologic | 1 | 2017 | 22 | 0.140 |
Why?
|
| Mobius Syndrome | 1 | 2017 | 8 | 0.140 |
Why?
|
| Family | 2 | 2013 | 564 | 0.140 |
Why?
|
| Crystallization | 1 | 2017 | 83 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 240 | 0.140 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2017 | 27 | 0.140 |
Why?
|
| Tubulin | 1 | 2017 | 103 | 0.130 |
Why?
|
| RNA Splice Sites | 1 | 2017 | 88 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 410 | 0.130 |
Why?
|
| Hip Joint | 1 | 2016 | 37 | 0.130 |
Why?
|
| Protein Stability | 1 | 2017 | 161 | 0.130 |
Why?
|
| Bone Development | 2 | 2014 | 57 | 0.130 |
Why?
|
| Whole Genome Sequencing | 1 | 2018 | 282 | 0.130 |
Why?
|
| Blood Platelets | 1 | 2019 | 327 | 0.130 |
Why?
|
| Autoantigens | 1 | 2017 | 118 | 0.130 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 244 | 0.130 |
Why?
|
| Multigene Family | 1 | 2017 | 299 | 0.130 |
Why?
|
| 1-Carboxyglutamic Acid | 1 | 2015 | 2 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 209 | 0.130 |
Why?
|
| Eye Abnormalities | 1 | 2016 | 104 | 0.130 |
Why?
|
| Models, Biological | 1 | 2021 | 1460 | 0.130 |
Why?
|
| Tibial Fractures | 1 | 2016 | 60 | 0.130 |
Why?
|
| Musculoskeletal Abnormalities | 2 | 2018 | 71 | 0.130 |
Why?
|
| Organ Size | 1 | 2017 | 436 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 546 | 0.130 |
Why?
|
| Microfilament Proteins | 2 | 2021 | 276 | 0.130 |
Why?
|
| Protein Isoforms | 1 | 2017 | 404 | 0.130 |
Why?
|
| Antibodies | 1 | 2017 | 375 | 0.120 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 97 | 0.120 |
Why?
|
| Macaca fascicularis | 1 | 2015 | 87 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2015 | 10 | 0.120 |
Why?
|
| Infant, Newborn | 5 | 2021 | 8162 | 0.120 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 529 | 0.120 |
Why?
|
| Chondrodysplasia Punctata | 1 | 2015 | 15 | 0.120 |
Why?
|
| Steroid Isomerases | 1 | 2015 | 8 | 0.120 |
Why?
|
| Myosins | 1 | 2015 | 46 | 0.120 |
Why?
|
| Metabolomics | 1 | 2019 | 423 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2018 | 492 | 0.120 |
Why?
|
| Arthrogryposis | 1 | 2015 | 35 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2015 | 63 | 0.120 |
Why?
|
| Glucose Intolerance | 1 | 2015 | 78 | 0.120 |
Why?
|
| Alopecia | 1 | 2015 | 39 | 0.120 |
Why?
|
| Glycoproteins | 1 | 2017 | 370 | 0.120 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2014 | 4 | 0.120 |
Why?
|
| Nephrocalcinosis | 1 | 2014 | 7 | 0.120 |
Why?
|
| Age of Onset | 2 | 2013 | 591 | 0.120 |
Why?
|
| Hypophosphatemia | 1 | 2014 | 10 | 0.120 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2014 | 13 | 0.120 |
Why?
|
| Age Factors | 1 | 2021 | 2807 | 0.110 |
Why?
|
| Deafness | 1 | 2015 | 82 | 0.110 |
Why?
|
| Zebrafish | 1 | 2017 | 380 | 0.110 |
Why?
|
| TRPV Cation Channels | 1 | 2014 | 33 | 0.110 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2014 | 10 | 0.110 |
Why?
|
| Connective Tissue | 1 | 2014 | 24 | 0.110 |
Why?
|
| Skeleton | 1 | 2014 | 5 | 0.110 |
Why?
|
| Dwarfism | 1 | 2015 | 98 | 0.110 |
Why?
|
| Cyclophilins | 1 | 2014 | 19 | 0.110 |
Why?
|
| Nails, Malformed | 1 | 2013 | 7 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 359 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2017 | 760 | 0.110 |
Why?
|
| Thiophenes | 1 | 2014 | 70 | 0.110 |
Why?
|
| Inflammation | 1 | 2021 | 1440 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 270 | 0.110 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 375 | 0.110 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2014 | 54 | 0.110 |
Why?
|
| Forearm | 1 | 2013 | 45 | 0.110 |
Why?
|
| Protein Interaction Maps | 1 | 2014 | 78 | 0.110 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2013 | 34 | 0.110 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 18 | 0.110 |
Why?
|
| Cleidocranial Dysplasia | 1 | 2013 | 6 | 0.110 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 123 | 0.110 |
Why?
|
| Proteolysis | 1 | 2014 | 172 | 0.110 |
Why?
|
| Myofibromatosis | 1 | 2013 | 7 | 0.110 |
Why?
|
| Flavoproteins | 1 | 2013 | 16 | 0.110 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 69 | 0.110 |
Why?
|
| Brachydactyly | 1 | 2013 | 10 | 0.110 |
Why?
|
| Laser Capture Microdissection | 1 | 2013 | 7 | 0.110 |
Why?
|
| Epilepsy | 1 | 2021 | 873 | 0.110 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2013 | 10 | 0.100 |
Why?
|
| Toes | 1 | 2013 | 28 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 79 | 0.100 |
Why?
|
| Hepatocytes | 1 | 2014 | 208 | 0.100 |
Why?
|
| Protein Folding | 1 | 2014 | 216 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2018 | 835 | 0.100 |
Why?
|
| Internationality | 1 | 2013 | 130 | 0.100 |
Why?
|
| Myopia | 1 | 2015 | 192 | 0.100 |
Why?
|
| Mice, Nude | 1 | 2014 | 710 | 0.100 |
Why?
|
| Ectodermal Dysplasia | 1 | 2013 | 45 | 0.100 |
Why?
|
| Physicians | 1 | 2019 | 581 | 0.100 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2012 | 6 | 0.100 |
Why?
|
| Fibrillins | 1 | 2012 | 31 | 0.100 |
Why?
|
| Exosomes | 1 | 2013 | 44 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2018 | 1369 | 0.100 |
Why?
|
| Osteopetrosis | 1 | 2012 | 13 | 0.100 |
Why?
|
| Osteosclerosis | 1 | 2012 | 12 | 0.100 |
Why?
|
| Patella | 1 | 2012 | 25 | 0.100 |
Why?
|
| Fibrillin-1 | 1 | 2012 | 58 | 0.100 |
Why?
|
| Scrotum | 1 | 2012 | 24 | 0.100 |
Why?
|
| Hand | 1 | 2013 | 100 | 0.100 |
Why?
|
| Dependovirus | 1 | 2013 | 128 | 0.100 |
Why?
|
| Self Report | 1 | 2015 | 517 | 0.100 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2012 | 38 | 0.100 |
Why?
|
| Databases, Nucleic Acid | 1 | 2012 | 70 | 0.100 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2013 | 142 | 0.100 |
Why?
|
| Jagged-1 Protein | 1 | 2012 | 52 | 0.100 |
Why?
|
| Absorptiometry, Photon | 1 | 2012 | 177 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2021 | 6132 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2012 | 85 | 0.100 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1399 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 228 | 0.090 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1327 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2014 | 333 | 0.090 |
Why?
|
| Protein Kinases | 1 | 2013 | 332 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 579 | 0.090 |
Why?
|
| Mass Spectrometry | 3 | 2019 | 330 | 0.090 |
Why?
|
| Genome, Human | 1 | 2018 | 1273 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 814 | 0.090 |
Why?
|
| Alleles | 3 | 2024 | 1615 | 0.090 |
Why?
|
| Hemophilia A | 1 | 2011 | 21 | 0.090 |
Why?
|
| Factor VIII | 1 | 2011 | 45 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 684 | 0.090 |
Why?
|
| Quality of Life | 2 | 2021 | 1936 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2161 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 1330 | 0.080 |
Why?
|
| Syndrome | 3 | 2018 | 1119 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 539 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2009 | 92 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2018 | 2593 | 0.080 |
Why?
|
| Middle Aged | 7 | 2019 | 26884 | 0.070 |
Why?
|
| Exons | 2 | 2022 | 797 | 0.070 |
Why?
|
| Transcriptome | 1 | 2014 | 953 | 0.070 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2022 | 101 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 575 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 3345 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 1685 | 0.070 |
Why?
|
| Neck | 2 | 2018 | 133 | 0.070 |
Why?
|
| DNA | 1 | 2012 | 1605 | 0.070 |
Why?
|
| Deficiency Diseases | 1 | 2006 | 11 | 0.070 |
Why?
|
| Drosophila | 2 | 2024 | 775 | 0.070 |
Why?
|
| Face | 2 | 2018 | 179 | 0.070 |
Why?
|
| Amino Acid Substitution | 2 | 2018 | 398 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2021 | 1396 | 0.060 |
Why?
|
| Chromosome Deletion | 1 | 2009 | 646 | 0.060 |
Why?
|
| Diet, Protein-Restricted | 1 | 2006 | 81 | 0.060 |
Why?
|
| Kidney | 1 | 2012 | 1367 | 0.060 |
Why?
|
| Quantitative Trait Loci | 1 | 2006 | 288 | 0.060 |
Why?
|
| Reference Values | 1 | 2006 | 715 | 0.060 |
Why?
|
| GTPase-Activating Proteins | 2 | 2016 | 86 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 920 | 0.060 |
Why?
|
| Chromatography, Liquid | 2 | 2017 | 196 | 0.060 |
Why?
|
| Allosteric Regulation | 2 | 2014 | 48 | 0.050 |
Why?
|
| NIH 3T3 Cells | 1 | 2023 | 92 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2024 | 78 | 0.050 |
Why?
|
| Brain | 1 | 2015 | 2997 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 1290 | 0.050 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2022 | 9 | 0.050 |
Why?
|
| TCF Transcription Factors | 1 | 2022 | 17 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 312 | 0.050 |
Why?
|
| Genes, Dominant | 2 | 2013 | 245 | 0.050 |
Why?
|
| Neural Crest | 1 | 2022 | 55 | 0.050 |
Why?
|
| Butylamines | 1 | 2022 | 1 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 223 | 0.050 |
Why?
|
| Histidine | 1 | 2022 | 73 | 0.050 |
Why?
|
| Injections, Intra-Articular | 1 | 2021 | 26 | 0.050 |
Why?
|
| beta Catenin | 1 | 2022 | 203 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2023 | 700 | 0.050 |
Why?
|
| Muscle Hypotonia | 1 | 2022 | 187 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 558 | 0.040 |
Why?
|
| Cornea | 2 | 2017 | 652 | 0.040 |
Why?
|
| Problem Behavior | 1 | 2021 | 37 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 96 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 5154 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2021 | 12363 | 0.040 |
Why?
|
| Alendronate | 1 | 2020 | 19 | 0.040 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 18 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 149 | 0.040 |
Why?
|
| Proteomics | 1 | 2023 | 501 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2021 | 173 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2013 | 1079 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2021 | 172 | 0.040 |
Why?
|
| PAX3 Transcription Factor | 1 | 2019 | 27 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2006 | 3292 | 0.040 |
Why?
|
| North America | 1 | 2019 | 239 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 2 | 2016 | 1113 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 55 | 0.040 |
Why?
|
| Carpal Joints | 1 | 2018 | 1 | 0.040 |
Why?
|
| Methylation | 1 | 2019 | 222 | 0.040 |
Why?
|
| Forelimb | 1 | 2018 | 15 | 0.040 |
Why?
|
| Synovial Fluid | 1 | 2018 | 15 | 0.040 |
Why?
|
| Synovial Membrane | 1 | 2018 | 27 | 0.040 |
Why?
|
| Ligaments, Articular | 1 | 2018 | 22 | 0.040 |
Why?
|
| Adipogenesis | 1 | 2019 | 72 | 0.040 |
Why?
|
| Horses | 1 | 2018 | 91 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2018 | 102 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 170 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2018 | 132 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2021 | 313 | 0.040 |
Why?
|
| Urea | 1 | 2019 | 231 | 0.040 |
Why?
|
| Cellular Senescence | 1 | 2019 | 161 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 187 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2018 | 291 | 0.040 |
Why?
|
| Chromosome Duplication | 1 | 2018 | 147 | 0.040 |
Why?
|
| White Matter | 1 | 2020 | 181 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2021 | 387 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2019 | 214 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 3714 | 0.040 |
Why?
|
| RNA Interference | 1 | 2019 | 500 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 265 | 0.030 |
Why?
|
| Dentin | 1 | 2017 | 2 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 664 | 0.030 |
Why?
|
| Facial Paralysis | 1 | 2017 | 35 | 0.030 |
Why?
|
| Karyotype | 1 | 2016 | 28 | 0.030 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2017 | 32 | 0.030 |
Why?
|
| Mosaicism | 1 | 2018 | 239 | 0.030 |
Why?
|
| Eczema | 1 | 2016 | 29 | 0.030 |
Why?
|
| Ocular Motility Disorders | 1 | 2017 | 38 | 0.030 |
Why?
|
| Ophthalmoplegia | 1 | 2017 | 54 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 58 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 465 | 0.030 |
Why?
|
| Facies | 1 | 2016 | 153 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2017 | 104 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2021 | 864 | 0.030 |
Why?
|
| Orbital Diseases | 1 | 2017 | 91 | 0.030 |
Why?
|
| Aged | 4 | 2015 | 19830 | 0.030 |
Why?
|
| Scoliosis | 1 | 2017 | 135 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 217 | 0.030 |
Why?
|
| Histones | 1 | 2019 | 525 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 505 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2018 | 369 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2013 | 16262 | 0.030 |
Why?
|
| Collagen Type IV | 1 | 2015 | 20 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 534 | 0.030 |
Why?
|
| Genes, X-Linked | 1 | 2015 | 59 | 0.030 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2015 | 50 | 0.030 |
Why?
|
| Sclera | 1 | 2015 | 57 | 0.030 |
Why?
|
| Hypercalciuria | 1 | 2014 | 7 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2014 | 57 | 0.030 |
Why?
|
| Amino Acids, Essential | 1 | 2014 | 26 | 0.030 |
Why?
|
| Hypercalcemia | 1 | 2014 | 39 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2014 | 47 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 73 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2014 | 76 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 428 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2014 | 314 | 0.030 |
Why?
|
| ADAMTS7 Protein | 1 | 2013 | 2 | 0.030 |
Why?
|
| Skin | 1 | 2017 | 519 | 0.030 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 2013 | 17 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2014 | 311 | 0.030 |
Why?
|
| Phenylpropionates | 1 | 2013 | 3 | 0.030 |
Why?
|
| Receptor, Notch3 | 1 | 2013 | 11 | 0.030 |
Why?
|
| Isoleucine | 1 | 2013 | 29 | 0.030 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2013 | 25 | 0.030 |
Why?
|
| Aorta | 1 | 2017 | 547 | 0.030 |
Why?
|
| Research Subjects | 1 | 2013 | 54 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 150 | 0.030 |
Why?
|
| Valine | 1 | 2013 | 115 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 295 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2013 | 179 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2015 | 198 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3415 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 357 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 794 | 0.020 |
Why?
|
| Consanguinity | 1 | 2012 | 115 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 503 | 0.020 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2012 | 16 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 1021 | 0.020 |
Why?
|
| Leucine | 1 | 2013 | 310 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 460 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 867 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 236 | 0.020 |
Why?
|
| Kinetics | 1 | 2013 | 1329 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2013 | 331 | 0.020 |
Why?
|
| Drug Tolerance | 1 | 2011 | 40 | 0.020 |
Why?
|
| Epigenomics | 1 | 2012 | 163 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 621 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1708 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1695 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 2048 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 1302 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2634 | 0.020 |
Why?
|
| Osteopoikilosis | 1 | 2009 | 1 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1752 | 0.020 |
Why?
|
| Pediatrics | 1 | 2018 | 1143 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2013 | 885 | 0.020 |
Why?
|
| Karyotyping | 1 | 2009 | 323 | 0.020 |
Why?
|
| Pregnancy | 1 | 2021 | 7171 | 0.020 |
Why?
|
| Cerebellum | 1 | 2012 | 415 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6584 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3561 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 2058 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 572 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2821 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 3728 | 0.020 |
Why?
|
| Aging | 1 | 2013 | 1183 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1695 | 0.020 |
Why?
|
| United States | 1 | 2018 | 10866 | 0.010 |
Why?
|